The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line

Nature Biotechnology

Volumn 29, Issue 8, 2011, Pages 735-741

  Xu, Xun ^a   Nagarajan, Harish ^b   Lewis, Nathan E ^b   Pan, Shengkai ^a   Cai, Zhiming ^c   Liu, Xin ^a   Chen, Wenbin ^a   Xie, Min ^a   Wang, Wenliang ^a   Hammond, Stephanie ^d   Andersen, Mikael R ^e   Neff, Norma ^f   Passarelli, Benedetto ^f   Koh, Winston ^f   Fan, H Christina ^f   Wang, Jianbin ^f   Gui, Yaoting ^c   Lee, Kelvin H ^d   Betenbaugh, Michael J ^g,h   Quake, Stephen R ^f   Famili, Iman ^b   Palsson, Bernhard O ^b,h   Wang, Jun ^a,i,j   more..

^a BGI SHENZHEN   (China)

^b GT Life Sciences   (United States)

^c Biomedical Research Institute   (China)

^d University of Delaware   (United States)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^f Stanford University   (United States)

^g Johns Hopkins University   (United States)

^h Chalmers University of Technology   (Denmark)

ⁱ Capital Region   (Denmark)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOPHARMACEUTICAL PROTEINS; CELL ENGINEERING; CELL LINES; CHINESE HAMSTER OVARY; CHO CELL; CHROMOSOMAL LOCATION; EXPONENTIAL GROWTH; GENOME SEQUENCES; GENOMIC SEQUENCE; HOST CELLS; RESISTANCE PROPERTIES; SUSCEPTIBILITY GENES; THERAPEUTIC PROTEIN;

ANIMAL CELL CULTURE; CHROMOSOMES; ESTERIFICATION; GLYCOSYLATION; PROTEINS; VIRUSES;

GENE THERAPY;

GLYCOSAMINOGLYCAN; MOLECULAR SCAFFOLD; N ACETYLGLUCOSAMINE; SULFOTRANSFERASE;

ANIMAL CELL; ARTICLE; BIOENGINEERING; CELL GROWTH; CHO CELL; CHO K1 CELL; CHROMOSOME; FUCOSYLATION; GENE LOCATION; GENETIC SUSCEPTIBILITY; GENOME; IMMUNOGENICITY; MICROFLUIDICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SEQUENCE ANALYSIS; SIALYLATION; SULFATION; VIRUS ENTRY; VIRUS RESISTANCE;

ANIMALS; CHO CELLS; CHROMOSOME MAPPING; CRICETINAE; CRICETULUS; GENOME; GENOMICS; GLYCOSYLATION; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

CRICETULUS GRISEUS;

EID: 79961191745     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.1932     Document Type: Article

References (55)

1. Walsh, G. Biopharmaceutical benchmarks 2010. Nat. Biotechnol. 28, 917-924 (2010).
2. Lim, Y. et al. Engineering mammalian cells in bioprocessing-current achievements and future perspectives. Biotechnol. Appl. Biochem. 55, 175-189 (2010).
3. Wurm, F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 22, 1393-1398 (2004). (Pubitemid 39482858)
4. Seth, G., Charaniya, S., Wlaschin, K.F. & Hu, W.S. In pursuit of a super producer-alternative paths to high producing recombinant mammalian cells. Curr. Opin. Biotechnol. 18, 557-564 (2007).
5. Derouazi, M. et al. Stability and cytogenetic characterization of recombinant CHO cell lines established by microinjection and phosphate transfection. in Cell Technology for Cell Products (ed. Smith, R.) 443-446 (Springer Netherlands, 2007).
6. Pilbrough, W., Munro, T.P. & Gray, P. Intraclonal protein expression heterogeneity in recombinant CHO cells. PLoS ONE 4, e8432 (2009).
7. Li, R. et al. De novo assembly of human genomes with massively parallel short read sequencing. Genome Res. 20, 265-272 (2010).
8. Miller, J.R., Koren, S. & Sutton, G. Assembly algorithms for next-generation sequencing data. Genomics 95, 315-327 (2010).
9. Fan, H.C., Wang, J., Potanina, A. & Quake, S.R. Whole-genome molecular haplotyping of single cells. Nat. Biotechnol. 29, 51-57 (2011).
10. Deaven, L.L. & Petersen, D.F. The chromosomes of CHO, an aneuploid Chinese hamster cell line: G-band, C-band, and autoradiographic analyses. Chromosoma 41, 129-144 (1973).
11. Kohany, O., Gentles, A.J., Hankus, L. & Jurka, J. Annotation, submission and screening of repetitive elements in Repbase: RepbaseSubmitter and Censor. BMC Bioinformatics 7, 474 (2006).
12. Smit, A., Hubley, R. & Green, P. RepeatMasker Open-3.0. 1996-2010 http://www.repeatmasker.org.
13. Smit, A. & Hubley, R. RepeatModeler Open-1.0. 2008-2010 http://www.repeatmasker.org.
14. Gibbs, R.A. et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428, 493-521 (2004).
15. Chinwalla, A.T. et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562 (2002). (Pubitemid 35477048)
16. Mullins, L.J. & Mullins, J.J. Insights from the rat genome sequence. Genome Biol. 5, 221 (2004).
17. Elsik, C.G. et al. Creating a honey bee consensus gene set. Genome Biol. 8, R13 (2007).
18. Walsh, G. & Jefferis, R. Post-translational modifications in the context of therapeutic proteins. Nat. Biotechnol. 24, 1241-1252 (2006). (Pubitemid 44564769)
19. Beck, A. et al. Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. Curr. Pharm. Biotechnol. 9, 482-501 (2008).
20. Campbell, C. & Stanley, P. A dominant mutation to ricin resistance in Chinese hamster ovary cells induces UDP-GlcNAc:glycopeptide beta-4-N-acetylglucosaminyltransferase III activity. J. Biol. Chem. 259, 13370-13378 (1984). (Pubitemid 15223868)
21. Kanda, Y. et al. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics. J. Biotechnol. 130, 300-310 (2007). (Pubitemid 46920544)
22. Natsume, A. et al. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region. J. Biochem. 140, 359-368 (2006). (Pubitemid 44703153)
23. Satoh, M., Iida, S. & Shitara, K. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies. Expert Opin. Biol. Ther. 6, 1161-1173 (2006). (Pubitemid 44714143)
24. Morell, A.G., Gregoriadis, G., Scheinberg, I.H., Hickman, J. & Ashwell, G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem. 246, 1461-1467 (1971).
25. Schellekens, H. Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clin. Ther. 24, 1720-1740, discussion 1719 (2002). (Pubitemid 35440946)
26. Sinclair, A.M. & Elliott, S. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J. Pharm. Sci. 94, 1626-1635 (2005). (Pubitemid 41360859)
27. Chou, H.H. et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl. Acad. Sci. USA 95, 11751-11756 (1998).
28. Ghaderi, D., Taylor, R.E., Padler-Karavani, V., Diaz, S. & Varki, A. Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat. Biotechnol. 28, 863-867 (2010).
29. Macher, B.A. & Galili, U. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim. Biophys. Acta 1780, 75-88 (2008).
30. Jenkins, N., Parekh, R.B. & James, D.C. Getting the glycosylation right: implications for the biotechnology industry. Nat. Biotechnol. 14, 975-981 (1996). (Pubitemid 26286569)
31. Bosques, C.J. et al. Chinese hamster ovary cells can produce galactose-alpha-1,3-galactose antigens on proteins. Nat. Biotechnol. 28, 1153-1156 (2010).
32. Yoo, E.M., Yu, L.J., Wims, L.A., Goldberg, D. & Morrison, S.L. Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. mAbs 2, 320-334 (2010).
33. Tyagi, M., Rusnati, M., Presta, M. & Giacca, M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276, 3254-3261 (2001).
34. Dechecchi, M.C. et al. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 75, 8772-8780 (2001). (Pubitemid 32768981)
35. Shukla, D. et al. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13-22 (1999). (Pubitemid 29468626)
36. Rostand, K.S. & Esko, J.D. Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65, 1-8 (1997). (Pubitemid 27008896)
37. Kobayashi, M., Habuchi, H., Yoneda, M., Habuchi, O. & Kimata, K. Molecular cloning and expression of Chinese hamster ovary cell heparan-sulfate 2-sulfotransferase. J. Biol. Chem. 272, 13980-13985 (1997). (Pubitemid 27224844)
38. Kobayashi, M., Habuchi, H., Habuchi, O., Saito, M. & Kimata, K. Purification and characterization of heparan sulfate 2-sulfotransferase from cultured Chinese hamster ovary cells. J. Biol. Chem. 271, 7645-7653 (1996). (Pubitemid 26107045)
39. Habuchi, H., Habuchi, O. & Kimata, K. Purification and characterization of heparan sulfate 6-sulfotransferase from the culture medium of Chinese hamster ovary cells. J. Biol. Chem. 270, 4172-4179 (1995).
40. Habuchi, H., Kobayashi, M. & Kimata, K. Molecular characterization and expression of heparan-sulfate 6-sulfotransferase. Complete cDNA cloning in human and partial cloning in Chinese hamster ovary cells. J. Biol. Chem. 273, 9208-9213 (1998). (Pubitemid 28176212)
41. Shieh, M.T., WuDunn, D., Montgomery, R.I., Esko, J.D. & Spear, P.G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116, 1273-1281 (1992).
42. Wiebe, M.E. et al. A Multifaceted Approach to Assure That Recombinant tPA is Free of Adventitious Virus (Butterworth-Heinemann, London, 1989).
43. Bushman, F.D. et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 5, e1000437 (2009).
44. Conner, J., Rixon, F.J. & Brown, S.M. Herpes simplex virus type 1 strain HSV1716 grown in baby hamster kidney cells has altered tropism for nonpermissive Chinese hamster ovary cells compared to HSV1716 grown in vero cells. J. Virol. 79, 9970-9981 (2005). (Pubitemid 41022338)
45. Gao, S.-d., Du, J.-z., Zhou, J.-h., Chang, H.-y. & Xie, Q.-g. Integrin activation and viral infection. Virol. Sin. 23, 1-7 (2008). (Pubitemid 351338143)
46. Gianni, T., Gatta, V. & Campadelli-Fiume, G. {alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. Proc. Natl. Acad. Sci. USA 107, 22260-22265 (2010).
47. Nakano, K. et al. Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule. Mol. Ther. 11, 617-626 (2005). (Pubitemid 40353119)
48. Sawitzky, D., Hampl, H. & Habermehl, K.O. Entry of pseudorabies virus into CHO cells is blocked at the level of penetration. Arch. Virol. 115, 309-316 (1990).
49. Xie, M. et al. Study on the relationship between level of CD58 expression in peripheral blood mononuclear cell and severity of HBV infection. Chin. Med. J. (Engl.) 118, 2072-2076 (2005). (Pubitemid 44848449)
50. Ianelli, C.J., DeLellis, R. & Thorley-Lawson, D.A. CD48 binds to heparan sulfate on the surface of epithelial cells. J. Biol. Chem. 273, 23367-23375 (1998). (Pubitemid 28417525)
51. Spehner, D., Gillard, S., Drillien, R. & Kirn, A. A cowpox virus gene required for multiplication in Chinese hamster ovary cells. J. Virol. 62, 1297-1304 (1988). (Pubitemid 18082943)
52. Feist, A.M. & Palsson, B.O. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat. Biotechnol. 26, 659-667 (2008). (Pubitemid 351824691)
53. Park, J.M., Kim, T.Y. & Lee, S.Y. Constraints-based genome-scale metabolic simulation for systems metabolic engineering. Biotechnol. Adv. 27, 979-988 (2009).
54. Yim, H. et al. Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat. Chem. Biol. 7, 445-452 (2011).
55. Hossler, P., Khattak, S.F. & Li, Z.J. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 19, 936-949 (2009).